Johnson & Johnson Unusual Options Activity For March 08

Deep-pocketed investors have adopted a bearish approach towards Johnson & Johnson JNJ, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in JNJ usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Johnson & Johnson. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 46% leaning bullish and 53% bearish. Among these notable options, 6 are puts, totaling $415,197, and 7 are calls, amounting to $480,591.

Predicted Price Range

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $125.0 to $165.0 for Johnson & Johnson over the recent three months.

Volume & Open Interest Development

Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Johnson & Johnson's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Johnson & Johnson's significant trades, within a strike price range of $125.0 to $165.0, over the past month.

Johnson & Johnson 30-Day Option Volume & Interest Snapshot

Biggest Options Spotted:

About Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women's health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.

In light of the recent options history for Johnson & Johnson, it's now appropriate to focus on the company itself. We aim to explore its current performance.

Present Market Standing of Johnson & Johnson

• Trading volume stands at 2,030,176, with JNJ's price up by 0.38%, positioned at $159.48.
• RSI indicators show the stock to be may be approaching overbought.
• Earnings announcement expected in 39 days.

What The Experts Say On Johnson & Johnson

Over the past month, 2 industry analysts have shared their insights on this stock, proposing an average target price of $198.0.

• An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $215.
• An analyst from RBC Capital has revised its rating downward to Outperform, adjusting the price target to $181.

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Johnson & Johnson options trades with real-time alerts from Benzinga Pro.